• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FVII激活蛋白酶可切割单链纤溶酶原激活剂。

The FVII activating protease cleaves single-chain plasminogen activators.

作者信息

Römisch J, Vermöhlen S, Feussner A, Stöhr H

机构信息

Aventis Behring GmbH, Research, Marburg, Germany.

出版信息

Haemostasis. 1999;29(5):292-9. doi: 10.1159/000022515.

DOI:10.1159/000022515
PMID:10754382
Abstract

A serine protease isolated from plasma sharing structural characteristics with a hepatocyte growth factor activator-like protease has been demonstrated recently to activate FVII. Accordingly, it was named 'FVII activator'. Until now an impact of this protease on the fibrinolytic system has not been reported. We islolated the protease from cryo-poor plasma by subsequent ion exchange chromatography and adsorption to immobilized heparin and/or aprotinin. Incubation of single-chain plasminogen activators (sc-PAs) with the FVII activator revealed significant activation of urokinase sc-PA (scu-PA) and tissue sc-PA (sct-PA) in vitro. It was enhanced in the presence of calcium and heparin. Compared to kallikrein, a more efficient activation of scu-PA was observed, whereas sct-PA appeared to be a poorer substrate for the FVI activator. At low protease concentrations and in the presence of heparin the scu-PA activation was comparable to plasmin. Employing recalcified whole blood thrombelastography, the lysis of initially formed fibrin was observed after addition of a combination of scu-PA and the FVII activator, whereas the scu-PA alone had a negligible effect at the concentration used. The study results as presented demonstrate that the FVII activator is a potent activator of sc-PAs in vitro. Whether it plays a physiological role in fibrinolysis deserves further investigation. Its comparatively high affinity to heparin assumes a function in cell surface or matrix events.

摘要

最近已证实,从血浆中分离出的一种丝氨酸蛋白酶与肝细胞生长因子激活剂样蛋白酶具有结构特征,可激活FVII。因此,它被命名为“FVII激活剂”。到目前为止,尚未报道这种蛋白酶对纤溶系统的影响。我们通过随后的离子交换色谱法以及吸附到固定化肝素和/或抑肽酶上,从乏冷沉淀血浆中分离出了该蛋白酶。单链纤溶酶原激活剂(sc-PAs)与FVII激活剂一起孵育显示,在体外尿激酶sc-PA(scu-PA)和组织sc-PA(sct-PA)有显著激活。在钙和肝素存在的情况下这种激活作用增强。与激肽释放酶相比,观察到scu-PA的激活更有效,而sct-PA似乎是FVI激活剂较差的底物。在低蛋白酶浓度和肝素存在的情况下,scu-PA的激活与纤溶酶相当。采用重新钙化的全血血栓弹力图法,在加入scu-PA和FVII激活剂的组合后,观察到最初形成的纤维蛋白溶解,而单独使用scu-PA在所使用的浓度下作用可忽略不计。所呈现的研究结果表明,FVII激活剂在体外是sc-PAs的有效激活剂。它是否在纤维蛋白溶解中发挥生理作用值得进一步研究。其对肝素相对较高的亲和力表明它在细胞表面或基质事件中起作用。

相似文献

1
The FVII activating protease cleaves single-chain plasminogen activators.FVII激活蛋白酶可切割单链纤溶酶原激活剂。
Haemostasis. 1999;29(5):292-9. doi: 10.1159/000022515.
2
Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way.细胞外组蛋白通过依赖于因子 VII 激活蛋白酶的单链尿激酶型纤溶酶原激活物促进纤维蛋白溶解。
Thromb Res. 2020 Dec;196:193-199. doi: 10.1016/j.thromres.2020.08.034. Epub 2020 Aug 23.
3
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
4
Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets.血小板相关纤溶酶原激活单链尿激酶型纤溶酶原激活物:血小板刺激纤维蛋白溶解的一种机制。
J Thromb Haemost. 2010 Jun;8(6):1313-22. doi: 10.1111/j.1538-7836.2010.03813.x. Epub 2010 Feb 17.
5
Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.尿激酶原:其在血浆中的稳定性及选择性纤溶作用机制的研究
Blood. 1986 May;67(5):1215-23.
6
Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.凝血因子VII与单链纤溶酶原激活物激活蛋白酶:酶原的激活与自身激活
Eur J Biochem. 2001 Jul;268(13):3789-96. doi: 10.1046/j.1432-1327.2001.02285.x.
7
Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).纤维蛋白结合对单链组织型纤溶酶原激活剂(t-PA)和单链嵌合纤溶酶原激活剂(t-PA/scu-PA)生化特性影响的比较
Blood Coagul Fibrinolysis. 1992 Feb;3(1):39-46. doi: 10.1097/00001721-199202000-00007.
8
Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.通过在纤溶酶切割位点融合获得的嵌合型(组织型/尿激酶型)纤溶酶原激活剂的特性。
Thromb Haemost. 1993 May 3;69(5):466-72.
9
Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.抑肽酶治疗的体外循环心脏手术患者中单链尿激酶型纤溶酶原激活剂(scu-PA)的保护作用。
Thromb Haemost. 1995 May;73(5):825-8.
10
A protease isolated from human plasma activating factor VII independent of tissue factor.一种从人血浆中分离出的蛋白酶,其激活因子VII不依赖组织因子。
Blood Coagul Fibrinolysis. 1999 Dec;10(8):471-9.

引用本文的文献

1
Elucidating the role of intrinsic adenosine A1 receptors in acute alcoholism using human-induced pluripotent stem cell-derived hepatocytes.利用人诱导多能干细胞衍生的肝细胞阐明内源性腺苷 A1 受体在急性酒精中毒中的作用。
Biosci Rep. 2024 Mar 29;44(3). doi: 10.1042/BSR20231682.
2
Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature.颈动脉狭窄的当前生物标志物:文献综述
Metabolites. 2023 Aug 5;13(8):919. doi: 10.3390/metabo13080919.
3
Factor VII Activating Protease (FSAP) and Its Importance in Hemostasis-Part I: FSAP Structure, Synthesis and Activity Regulation: A Narrative Review.
因子 VII 激活蛋白酶 (FSAP) 及其在止血中的重要性 - 第 I 部分:FSAP 结构、合成和活性调节:叙述性综述。
Int J Mol Sci. 2023 Mar 13;24(6):5473. doi: 10.3390/ijms24065473.
4
Factor VII Activating Protease Expression in Human Platelets and Accumulation in Symptomatic Carotid Plaque.人血小板中因子 VII 激活蛋白酶的表达及其在有症状颈动脉斑块中的积累。
J Am Heart Assoc. 2020 Sep;9(17):e016445. doi: 10.1161/JAHA.120.016445. Epub 2020 Aug 28.
5
Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model.新型 pVII 组合噬菌体展示肽文库的设计与特性分析,用于使用 VII 因子激活蛋白酶(FSAP)作为模型进行蛋白酶底物挖掘。
Chembiochem. 2020 Jul 1;21(13):1875-1884. doi: 10.1002/cbic.201900705. Epub 2020 Apr 14.
6
Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity.全基因组分析循环因子 VII 激活蛋白酶 (FSAP) 活性的遗传决定因素。
J Thromb Haemost. 2018 Oct;16(10):2024-2034. doi: 10.1111/jth.14258. Epub 2018 Aug 24.
7
Whole-exome sequencing in evaluation of patients with venous thromboembolism.全外显子组测序在静脉血栓栓塞症患者评估中的应用
Blood Adv. 2017 Jun 29;1(16):1224-1237. doi: 10.1182/bloodadvances.2017005249. eCollection 2017 Jul 11.
8
Role of glycine 221 in catalytic activity of hyaluronan-binding protein 2.甘氨酸221在透明质酸结合蛋白2催化活性中的作用。
J Biol Chem. 2017 Apr 14;292(15):6381-6388. doi: 10.1074/jbc.M116.757849. Epub 2017 Feb 27.
9
Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.种系HABP2突变导致家族性非髓样甲状腺癌。
N Engl J Med. 2015 Jul 30;373(5):448-55. doi: 10.1056/NEJMoa1502449.
10
Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.循环因子 VII 激活蛋白酶(FSAP)及口服ω-3 脂肪酸补充剂与心房颤动患者临床结局的关联:OMEGA-AF 研究
J Thromb Thrombolysis. 2014 Apr;37(3):317-25. doi: 10.1007/s11239-013-0921-0.